Looking to publish in Immunopharmacology and Immunotoxicology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginImmunopharmacology and Immunotoxicology publishes manuscripts on drug discovery, pre-clinical and clinical development of agents targeting the immune system, and immunotoxicology of defined drug compounds. It focuses on anti-inflammatory treatments, cancer immunotherapy, vaccines, small molecules, biologics, and cell-based therapies, and covers immune-mediated diseases, cancer immunology, infections, transplantation, allergy, chronic kidney disease, neurodegenerative disorders, immunodeficiencies, neurology, inflammatory atherosclerosis, and related areas. The journal considers mechanism-of-action studies, in vitro and pre-clinical animal studies, and non-interventional and interventional clinical studies.
Looking to publish in Immunopharmacology and Immunotoxicology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Immunopharmacology and Immunotoxicology accepts the following article types. Click on an article type to view submission instructions.
Original Manuscripts
Mini-Reviews
Review
Clinical Trials
Research Article
Brief Communication
Clinical Cases
Clinical Note
Letter
Recent Publications
FKBP5 promotes pro-inflammatory microglial activation and neuronal injury through NF-κB/NLRP3 signaling in convulsive status epilepticus
Haiping Zhang, Lin Wu, Ting Su, Mei Yuan
N6-methyladenosine-modified circ_0081069: an effective approach to modulate breast cancer’s tumor immune microenvironment
Jinghui Peng, Yue Huang, Wentong Fang, Mingjie Zheng
Improvement of post-COVID-19 vaccination dysautonomia with GLP-1 receptor agonist
Svetlana Blitshteyn, Jill R Schofield, Nichole Haire, Lawrence B Afrin
Sustained Clinical Quiescence in Anti-Scl-70 Positive Systemic Sclerosis During Long-Term Entecavir Therapy: A Potential Role for NLRP3 Inflammasome Inhibition?
Angelo Nigro
Nephroprotective effect of vitamin E and sodium selenite against azithromycin-induced renal toxicity in a rat model: attenuation of oxidative stress, inflammation, and apoptosis
Marwan A. Ibrahim, Ibrahim M Ibrahim Laila, Ayman M. Algohary, Mai M. Anwar
Frequently asked questions
How long does it take to publish?
Optional Accelerated Publication offers a final decision in as little as 3 weeks from submission, with peer review in approximately 2 weeks, online publication usually 1-2 weeks after acceptance, first proofs within 5 working days, and proof corrections requested within 48 hours.
Reformat to Immunopharmacology and Immunotoxicology using Livewrite PremiumIs a cover letter required?
Journals may require authors to sign a letter certifying that legal and ethical requirements for humane treatment of animals have been met.
Reformat to Immunopharmacology and Immunotoxicology using Livewrite PremiumWhat are the publication costs?
Institutional online-only subscription is USD 6,695.00 and print & online subscription is USD 9,791.00.
Reformat to Immunopharmacology and Immunotoxicology using Livewrite Premium